Irinotecan Upregulates Fibroblast Growth Factor Receptor 3 Expression in Colorectal Cancer Cells, Which Mitigates Irinotecan-Induced Apoptosis()()

BACKGROUND: Irinotecan (IRI) is an integral part of colorectal cancer (CRC) therapy, but response rates are unsatisfactory and resistance mechanisms are still insufficiently understood. As fibroblast growth factor receptor 3 (FGFR3) mediates essential survival signals in CRC, it is a candidate gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Erdem, Zeynep N., Schwarz, Stefanie, Drev, Daniel, Heinzle, Christine, Reti, Andrea, Heffeter, Petra, Hudec, Xenia, Holzmann, Klaus, Grasl-Kraupp, Bettina, Berger, Walter, Grusch, Michael, Marian, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367848/
https://www.ncbi.nlm.nih.gov/pubmed/28340475
http://dx.doi.org/10.1016/j.tranon.2017.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367848/
https://www.ncbi.nlm.nih.gov/pubmed/28340475
http://dx.doi.org/10.1016/j.tranon.2017.02.004

Ejemplares similares